Castleark Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-130,765
Closed -$31.9M 368
2021
Q4
$31.9M Sell
130,765
-290
-0.2% -$63.5K 1.17% 20
2021
Q3
$25.4M Sell
131,055
-22,730
-15% -$4.59M 0.97% 25
2021
Q2
$28.7M Sell
153,785
-15,850
-9% -$2.75M 0.96% 26
2021
Q1
$26.7M Sell
169,635
-2,990
-2% -$474K 0.96% 26
2020
Q4
$28.6M Sell
172,625
-4,575
-3% -$744K 1.07% 26
2020
Q3
$29.3M Sell
177,200
-15,480
-8% -$2.38M 1.15% 23
2020
Q2
$26.4M Buy
192,680
+177,380
+1,159% +$23.2M 1.15% 20
2020
Q1
$1.8M Buy
+15,300
New +$2.01M 0.11% 156

Other funds holding ZTS

Castleark Management's ZTS Position: Q1 2022 in Review

Castleark Management sold out of Zoetis (ZTS) in Q1 2022, closing a stake of 130,765 shares — an estimated $31.9M sold.

Castleark Management first reported a position in ZTS in Q1 2020 and held it in 8 quarters. The position peaked at $31.9M in Q4 2021. 1,637 funds tracked by Wall St. Rank hold ZTS as of Q1 2022.

  • Castleark Management reported no remaining Zoetis position as of Q1 2022 after selling out during the quarter.
  • Castleark Management sold 130,765 Zoetis shares in Q1 2022, an estimated $31.9M.
  • Castleark Management first reported a position in Zoetis in Q1 2020 and held it in 8 quarters.
  • Castleark Management's Zoetis position peaked at $31.9M in Q4 2021.
  • 1,637 funds tracked by Wall St. Rank held Zoetis as of Q1 2022.

Based on Castleark Management's 13F filing for Q1 2022, filed 16 May 2022.